3rd Circ. Urged To Revive Fosamax MDL

By Emily Field (May 24, 2023, 6:56 PM EDT) -- Fosamax patients have told the Third Circuit a lower court's decision to toss multidistrict litigation alleging Merck failed to warn of the osteoporosis drug's atypical femoral fracture risk is "riddled with errors" and ignores years of science about the types of fractures at issue....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!